Fundacio Assistencial De Mutua De Terrassa Fpc — Clinical Trial Site

65 Registered trials

22 Currently recruiting

Organisation

Fundacio Assistencial De Mutua De Terrassa Fpc

Location

Terrassa, Spain

Identifier

ORG-100044208

Address

Calle De San Antonio No 32, 08221, Spain

Departments

#354: Neurology
#3802:UCI/medicina intensiva
#40453; Unitat de Recerca de Neurologia
#40453: Neurologia
#40453: Unitat de Recerca de Neurologia
3001; Enfermedades Infecciosas
7003:Oncologia
9406:Oncologia
Cardiology department
Clinical Haematology
Gastroenterology
Haematology
Hematología
Hematology
Intensive Care Medicine
Intensive Care Unit
Medica Oncology
Medical Doctor
Medical Oncology
Medicina Interna
N/A
NA
Neurologia
Neurology
Neurology Department
Obstetrician and Gynecologist
Oncology
Oncology Department
Orthopedic Surgery and Traumatology Service (Knee Unit)
PADES
Servicio de digestivo
Servicio de Neurología

Clinical trials at this site (65)

Search interface

A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown

2025-523766-25-00 Ulcerative colitis 5
Open-label Extension of KarXT + KarX-EC for Agitation in Alzheimer’s Disease Pending

2024-519994-20-00 Agitation Associated with Alzheimer’s Disease 5
A randomised, double-blind, comparative clinical trial of the effectiveness and tolerability of fentanyl in continuous parenteral perfusion … Pending

2024-520025-36-00 To evaluate the effectiveness and tolerability of fenta 11
A study to test if tenecteplase helps people to recover from an acute stroke when given more than 4.5 hours after the person was last seen w… Pending

2025-522542-40-00 Acute Ischemic Stroke 5
Optimizing Aspirin Use for Preeclampsia Prevention Pending

2025-524646-94-00 Obstetrics – Preeclampsia 11
Immunosuppressant Discontinuation in Elderly patients with ulcerative colitis And long-term remission Pending

2025-524675-23-00 Ulcerative Colitis 6
A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures Recruiting

2025-524038-24-00 Focal Epilepsy 5 2026-05-22
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
An Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD) Recruiting

2024-518006-40-00 Early Symptomatic Alzheimer’s Disease (MCI to Mild Deme 5 2025-11-13
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis Recruiting

2024-512126-29-00 Generalized Myasthenia Gravis 5 2025-02-25
A Study of Zanubrutinib Versus Lenalidomide in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma (MAHOGANY) Recruiting

2022-502548-12-00 marginal zone lymphoma 5 2023-09-28
A Phase 3b study to learn more about the safety and tolerability of ivosidenib in combination with azacitidine in adult patients newly diagn… Recruiting

2022-501709-11-00 Isocitrate deshydrogenase1 mutation-positive (IDH1m) ac 5 2023-06-06
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy. Recruiting

2025-521640-38-00 Focal onset seizures or primary generalized tonic-cloni 5 2025-10-16
A clinical study of MK-2214 in people with Alzheimer’s disease (MK-2214-004) Recruiting

2024-519190-19-00 Alzheimer’s Disease 4 2025-10-03
Prospective Randomized Evaluation of Emerging Novel Treatments for Infection prophylaxis in Total Joint Replacement (PREVENT-iT) Recruiting

2024-515055-38-00 Adult patients undergoing TJR surgery. 5 2025-02-13
Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions (DEXA-REFINE) Recruiting

2024-519759-27-00 Acute Hypoxemic Respiratory Failure 6 2024-12-20
A study to determine if BHV-7000 is safe in adults with refractory focal onset epilepsy Recruiting

2023-508813-18-00 Refractory Focal Onset Epilepsy 4 2024-12-18
Use of statins in patients with intracerebral hemorrhage Recruiting

2024-511465-11-00 Spontaneous lobar ICH 5 2024-11-20
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides difficile Infection: The Re… Recruiting

2022-502972-22-00 Clostridioides difficile infection. 5 2024-10-31
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting

2023-508811-21-00 Refractory Focal Onset Epilepsy 10 2024-09-25
A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaLuate the effIcacy and safety of abeLacimab… Recruiting

2023-503224-66-00 Atrial Fibrillation 5 2023-10-31
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination… Recruiting

2023-503442-30-00 Multiple Myeloma 5 2022-10-14
An extension study to learn if Staccato Alprazolam is safe when treating long seizures in children ≥12 years of age and adults Recruiting

2023-508868-30-00 Treatment of stereotypical prolonged seizure 5 2022-09-26